|
Volumn 27, Issue 2, 2008, Pages 199-206
|
Erratum: 'The need for reorientation toward cost-effective prediction: Comments on 'evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M.J. Pencina, R. B. D'Agostino Sr, R. B. D'Agostino Jr, and R.S. Vasan (Statistics in Medicine (2007) 10.1002/sim.2995);The need for reorientation toward cost-effective prediction: Comments on 'Evaluating the added predictive of a new marker: From area under the ROC curve to reclassification and beyond' by M.J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
BAYES THEOREM;
CANCER SCREENING;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
DATA ANALYSIS;
HEALTH CARE COST;
HUMAN;
NOTE;
OUTCOME ASSESSMENT;
PREDICTION;
PROBABILITY;
PROGNOSIS;
PROPORTIONAL HAZARDS MODEL;
PROSTATE CANCER;
RISK ASSESSMENT;
ROC CURVE;
SENSITIVITY AND SPECIFICITY;
STATISTICAL MODEL;
|
EID: 38849183343
PISSN: 02776715
EISSN: 10970258
Source Type: Journal
DOI: 10.1002/sim.3155 Document Type: Erratum |
Times cited : (58)
|
References (7)
|